Market Research Industry Reports

KPI Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

KPI Therapeutics Inc (KPI), formerly Kineta Prime Inc is a biotechnology company that develops therapies for autoimmunity and chronic pain. The company provides pipeline products such as Dalazatide, a synthetic peptide for the treatment of autoimmune disorders; KPI-190, an eye drop developed for several eye diseases such as uveitis, dry eye syndrome; and KPI-150, a topical cream for atopic dermatitis, psoriasis, and other dermatological complications associated with inflammatory diseases. KPI also develops chronic pain platform products which include Conopeptide, a amino acid peptide conotoxin being developed for traumatic injury pain, neuropathic pain indications and burn pain. KPI is headquartered in Seattle, Washington, the US.

KPI Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

3
List of Tables 4
List of Figures 4
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPI Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
KPI Therapeutics Raises Funds through Venture Financing 10
KPI Therapeutics Raises USD0.5 Million in Venture Financing 11
KPI Therapeutics Raises USD0.03 Million in Venture Financing 12
KPI Therapeutics Raises USD1.6 Million in Venture Financing 13
Partnerships 14
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 14
KPI Therapeutics Inc - Key Competitors 15
KPI Therapeutics Inc - Key Employees 16
KPI Therapeutics Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
06/20/2016: Dalazatide as a Potential Immunotherapy for Lupus to be Presented at Immunology Conference 18
06/10/2016: Alliance for Children Therapeutics Presents Dalazatide Data Demonstrating Positive Response in Lupus 19
05/23/2016: KPI Therapeutics to Present Updated Dalazatide Study Data in Lupus 20
05/11/2016: KPI Therapeutics Non-Opiate Pain Drug Effective in Neuropathic Pain and Burn Pain 21
02/08/2016: KPI Therapeutics Initiates Research Program In Eye Diseases 22
02/08/2016: KPI Therapeutics Initiates Research Program In Skin Diseases 23
Clinical Trials 24
May 12, 2016: KPI Therapeutics Presents Dalazatide Plaque Psoriasis Data at Dermatology Conference 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables

List of Tables
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPI Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPI Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
KPI Therapeutics Raises Funds through Venture Financing 10
KPI Therapeutics Raises USD0.5 Million in Venture Financing 11
KPI Therapeutics Raises USD0.03 Million in Venture Financing 12
KPI Therapeutics Raises USD1.6 Million in Venture Financing 13
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 14
KPI Therapeutics Inc, Key Competitors 15
KPI Therapeutics Inc, Key Employees 16

GVKPIL – Goindwal Sahib Thermal Power Plant Expansion 1320 MW – Punjab - Project Profile

Synopsis GVKPIL Goindwal Sahib Thermal Power Plant Expansion 1320 MW Punjab - Project Profile contains information on the scope of the project including project overview and location. The profile

USD 75View Report

KPI – Atyrau Petrochemical Complex – Kazakhstan - Project Profile

Synopsis KPI Atyrau Petrochemical Complex Kazakhstan- Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership and funding,

USD 75View Report

Insys Therapeutics Inc (INSY) - Product Pipeline Analysis, 2018 Update

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to

USD 750View Report

Ocera Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Ocera Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Ocera Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Nov 2017
No. of Pages :25
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube